PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial, page-190

  1. 465 Posts.
    lightbulb Created with Sketch. 125
    The consistently positive results speak for themselves and, these are scientifically based and independent of the capping and manipulation now going on by vested interests. We all understand that this goes on but it's disappointing, and unsettling for some, and puts a cloud over what should be cheered as a great next step for the Company. Let's hope the PTX PR team is up to the task as well... whereas the regulators are just toothless tigers !
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.